Suppr超能文献

在经过训练和未经训练的男性进行剧烈运动时,β受体阻滞剂会降低潮气量。

Beta-blockade reduces tidal volume during heavy exercise in trained and untrained men.

作者信息

Joyner M J, Jilka S M, Taylor J A, Kalis J K, Nittolo J, Hicks R W, Lohman T G, Wilmore J H

出版信息

J Appl Physiol (1985). 1987 May;62(5):1819-25. doi: 10.1152/jappl.1987.62.5.1819.

Abstract

The effects of beta-blockade on tidal volume (VT), breath cycle timing, and respiratory drive were evaluated in 14 endurance-trained [maximum O2 uptake (VO2max) approximately 65 ml X kg-1 X min-1] and 14 untrained (VO2max approximately 50 ml X kg-1 X min-1) male subjects at 45, 60, and 75% of unblocked VO2max and at VO2max. Propranolol (PROP, 80 mg twice daily), atenolol (ATEN, 100 mg once a day) and placebo (PLAC) were administered in a randomized double-blind design. In both subject groups both drugs attenuated the increases in VT associated with increasing work rate. CO2 production (VCO2) was not changed by either drug during submaximal exercise but was reduced in both subject groups by both drugs during maximal exercise. The relationship between minute ventilation (VE) and VCO2 was unaltered by either drug in both subject groups due to increases in breathing frequency. In trained subjects VT was reduced during maximal exercise from 2.58 l/breath on PLAC to 2.21 l/breath on PROP and to 2.44 l/breath on ATEN. In untrained subjects VT at maximal exercise was reduced from 2.30 l/breath on PLAC to 1.99 on PROP and 2.12 on ATEN. These observations indicate that 1) since VE vs. VCO2 was not altered by beta-adrenergic blockade, the changes in VT and f did not result from a general blunting of the ventilatory response to exercise during beta-adrenergic blockade; and 2) blockade of beta 1- and beta 2-receptors with PROP caused larger reductions in VT compared with blockade of beta 1-receptors only (ATEN), suggesting that beta 2-mediated bronchodilation plays a role in the VT response to heavy exercise.

摘要

在14名耐力训练的男性受试者[最大摄氧量(VO₂max)约为65 ml·kg⁻¹·min⁻¹]和14名未经训练的男性受试者(VO₂max约为50 ml·kg⁻¹·min⁻¹)中,分别在未阻断VO₂max的45%、60%和75%以及VO₂max水平下,评估了β受体阻滞剂对潮气量(VT)、呼吸周期时间和呼吸驱动的影响。采用随机双盲设计给予普萘洛尔(PROP,每日两次,每次80 mg)、阿替洛尔(ATEN,每日一次,每次100 mg)和安慰剂(PLAC)。在两个受试者组中,两种药物均减弱了与工作率增加相关的VT增加。在次最大运动期间,两种药物均未改变二氧化碳产生量(VCO₂),但在最大运动期间,两种药物均使两个受试者组的VCO₂降低。由于呼吸频率增加,两个受试者组中两种药物均未改变分钟通气量(VE)与VCO₂之间的关系。在训练有素的受试者中,最大运动时VT从PLAC时的2.58 l/次呼吸降至PROP时的2.21 l/次呼吸和ATEN时的2.44 l/次呼吸。在未经训练的受试者中,最大运动时VT从PLAC时的2.30 l/次呼吸降至PROP时的1.99 l/次呼吸和ATEN时的2.12 l/次呼吸。这些观察结果表明:1)由于β肾上腺素能阻滞剂未改变VE与VCO₂的关系,因此VT和f的变化并非源于β肾上腺素能阻滞剂期间对运动通气反应的普遍减弱;2)与仅阻断β₁受体(ATEN)相比,用PROP阻断β₁和β₂受体导致VT更大程度的降低,这表明β₂介导的支气管舒张在对剧烈运动的VT反应中起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验